UPDATED Jun 25, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ACAD | US$15.60 | 4.9% | -35.6% | US$2.6b | US$27.16 | PS3.2x | E41.8% | n/a | ||
LEGN | US$43.52 | 7.5% | -39.7% | US$7.9b | US$82.50 | PS23.1x | E63.7% | n/a | ||
PRVB | US$24.98 | 2.7% | 456.3% | US$2.4b | US$24.00 | PS183.6x | E75.7% | n/a | ||
BGNE | US$150.99 | -2.4% | -16.3% | US$16.8b | US$267.01 | PS5.8x | E60.7% | n/a | ||
ITCI | US$72.42 | -4.1% | 15.5% | US$8.0b | US$92.22 | PS14.9x | E59.8% | n/a | ||
AXSM | US$79.01 | 3.9% | -5.2% | US$3.7b | US$123.75 | PS14.9x | E64.1% | n/a | ||
ADMA | US$11.01 | 3.7% | 184.5% | US$2.6b | US$11.00 | PS9x | E30.6% | n/a | ||
MDGL | US$280.04 | 1.5% | 37.4% | US$6.1b | US$365.07 | PB7x | E64.3% | n/a | ||
RETA | US$172.36 | 0.09% | 581.8% | US$6.6b | US$172.44 | PS279.7x | E62.0% | n/a | ||
XENE | US$37.00 | 2.1% | -7.8% | US$2.8b | US$58.79 | PB3.1x | E22.7% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
IOVA | US$8.45 | 5.6% | 11.9% | US$2.3b | US$25.75 | PS1241.9x | E64.5% | n/a | ||
RYTM | US$42.75 | 3.3% | 140.8% | US$2.6b | US$57.22 | PS28.4x | E65.6% | n/a | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
MRUS | US$56.78 | 4.7% | 131.3% | US$3.8b | US$84.18 | PS98.1x | E22.1% | n/a | ||
RCKT | US$23.85 | 15.3% | 18.7% | US$2.2b | US$50.08 | PB4.9x | E57.3% | n/a | ||
AGIO | US$44.69 | 5.0% | 58.9% | US$2.6b | US$52.83 | PS86.3x | E19.5% | n/a | ||
BPMC | US$106.55 | -0.1% | 69.2% | US$6.6b | US$119.41 | PS23.6x | E66.4% | n/a | ||
GERN | US$4.52 | 0.7% | 48.2% | US$2.7b | US$6.94 | PS5155.7x | E65.1% | n/a | ||
IMVT | US$27.29 | 4.2% | 45.2% | US$4.0b | US$49.14 | PB6.5x | E46.9% | n/a | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | ||
DNLI | US$22.39 | 8.6% | -23.2% | US$3.3b | US$38.67 | PS10.8x | E11.2% | n/a | ||
BIO | US$280.25 | -3.0% | -23.4% | US$8.1b | US$366.40 | PS3.1x | E32.8% | n/a | ||
IDYA | US$36.12 | -3.1% | 55.6% | US$2.8b | US$54.45 | PS176.3x | E42.3% | n/a |